{"entity":{"id":"nct06534762","kind":"trial","name":"Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Zhejiang Provincial People's Hospital, now recruiting.","summary":"Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study is a phase 2, interventional study registered as NCT06534762 by Zhejiang Provincial People's Hospital, with a registry enrolment figure of 260 participants, started 2024-07-15 and due to reach its primary completion in 2026-07-01. Interventions recorded: Mirabegron. Conditions listed: NSCLC; SCLC; Colorectal Cancer; Pancreas Cancer; TNBC - Triple-Negative Breast Cancer; DLBCL - Diffuse Large B Cell Lymphoma; Squamous Cell Carcinoma of Head and Neck. Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06534762","url":"https://clinicaltrials.gov/study/NCT06534762"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06534762","phase":"2","setting":"Efficacy and Safety of Milaberon in Combination With Standard Therapy in Advanced Solid Tumors: an Open, Multicenter, Clinical Study","sponsor":"Zhejiang Provincial People's Hospital","enrolled":260,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06534762/","neighbours":{"cancer":[{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}